Insider Buying: LifePoint Health Inc (LPNT) Chairman Buys 21,368 Shares of Stock
LifePoint Health Inc (NASDAQ:LPNT) Chairman William F. Carpenter III purchased 21,368 shares of LifePoint Health stock in a transaction on Wednesday, February 28th. The shares were acquired at an average price of $46.80 per share, for a total transaction of $1,000,022.40. Following the completion of the transaction, the chairman now directly owns 482,668 shares of the company’s stock, valued at $22,588,862.40. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Shares of LifePoint Health Inc (NASDAQ:LPNT) traded up $1.65 during trading on Friday, hitting $46.30. 772,226 shares of the stock traded hands, compared to its average volume of 614,905. The company has a debt-to-equity ratio of 1.26, a current ratio of 1.70 and a quick ratio of 1.49. LifePoint Health Inc has a 1 year low of $41.45 and a 1 year high of $67.95. The company has a market capitalization of $1,740.35, a PE ratio of 18.82, a price-to-earnings-growth ratio of 1.25 and a beta of 0.57.
LifePoint Health (NASDAQ:LPNT) last issued its earnings results on Friday, February 23rd. The company reported $0.77 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.81 by ($0.04). LifePoint Health had a return on equity of 6.34% and a net margin of 1.46%. The firm had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter in the prior year, the business posted $1.07 EPS. The firm’s revenue for the quarter was down 7.2% on a year-over-year basis. analysts forecast that LifePoint Health Inc will post 4.26 earnings per share for the current year.
A number of research analysts have commented on LPNT shares. William Blair reiterated an “outperform” rating on shares of LifePoint Health in a research report on Tuesday, November 21st. BidaskClub upgraded shares of LifePoint Health from a “strong sell” rating to a “sell” rating in a research report on Friday, December 15th. ValuEngine cut shares of LifePoint Health from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Goldman Sachs Group started coverage on shares of LifePoint Health in a research report on Wednesday, January 3rd. They set a “sell” rating and a $45.00 price target on the stock. Finally, Zacks Investment Research upgraded shares of LifePoint Health from a “strong sell” rating to a “hold” rating in a research report on Monday, January 22nd. One equities research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and six have assigned a buy rating to the stock. LifePoint Health presently has a consensus rating of “Hold” and a consensus target price of $55.00.
COPYRIGHT VIOLATION NOTICE: This piece was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another site, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this piece can be viewed at https://www.watchlistnews.com/insider-buying-lifepoint-health-inc-lpnt-chairman-buys-21368-shares-of-stock/1905288.html.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.